Quebec biotech firm produces a potential COVID-19 vaccine


A biotechnology company in Quebec City that previously developed and mass produced a flu vaccine says it has produced a potential vaccine for COVID-19.  This is not yet a coronavirus vaccine — at this stage it is a “vaccine candidate” that could still prove to be ineffective during several steps and test phases.  But as scientists around the world race to find a vaccine, the 20-day turnaround by the company, Medicago, is notable: vaccine candidates are typically developed on a scale of months or more.